sonar-pro
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.
{
  "id": "9dbdcd56-7934-4356-989e-ead7e9129362",
  "choices": [
    {
      "finish_reason": "stop",
      "index": 0,
      "logprobs": null,
      "message": {
        "content": "{\"status\":\"NO\",\"explanation\":\"The Philippines, as part of ASEAN and a country in Climatic Zone IVb, requires long-term stability data at 30°C/75% RH—not 25°C/60% RH—because it is classified as a hot, very humid climate and does not permit 25°C/60% RH data submission for pharmaceutical products unless specifically justified; accelerated stability studies cannot substitute for this requirement.[5]\"}",
        "refusal": null,
        "role": "assistant",
        "annotations": null,
        "audio": null,
        "function_call": null,
        "tool_calls": null
      },
      "delta": {
        "role": "assistant",
        "content": ""
      }
    }
  ],
  "created": 1755750210,
  "model": "sonar-pro",
  "object": "chat.completion",
  "service_tier": null,
  "system_fingerprint": null,
  "usage": {
    "completion_tokens": 91,
    "prompt_tokens": 31,
    "total_tokens": 122,
    "completion_tokens_details": null,
    "prompt_tokens_details": null,
    "search_context_size": "low",
    "cost": {
      "input_tokens_cost": 0.0,
      "output_tokens_cost": 0.001,
      "request_cost": 0.006,
      "total_cost": 0.007
    }
  },
  "citations": [
    "https://database.ich.org/sites/default/files/ICH_Q1EWG_Step2_Draft_Guideline_2025_0411.pdf",
    "https://database.ich.org/sites/default/files/Q1F_Stability_Guideline_WHO_2018.pdf",
    "http://academy.gmp-compliance.org/guidemgr/files/WHO_TRS_953_Annex2.pdf",
    "https://pmc.ncbi.nlm.nih.gov/articles/PMC11858995/",
    "https://asean.org/wp-content/uploads/i-Final-ASEAN-Guideline-on-Stability-Study-Drug-Product-R2_uniformed-template.pdf"
  ],
  "search_results": [
    {
      "title": "[PDF] STABILITY TESTING OF DRUG SUBSTANCES AND DRUG ... - ICH",
      "url": "https://database.ich.org/sites/default/files/ICH_Q1EWG_Step2_Draft_Guideline_2025_0411.pdf",
      "date": "2025-04-11",
      "last_updated": "2025-08-10"
    },
    {
      "title": "[PDF] Annex 10 - ICH",
      "url": "https://database.ich.org/sites/default/files/Q1F_Stability_Guideline_WHO_2018.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "[PDF] Annex 2 Stability testing of active pharmaceutical ingredients and ...",
      "url": "http://academy.gmp-compliance.org/guidemgr/files/WHO_TRS_953_Annex2.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "Accelerated Predictive Stability Testing",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11858995/",
      "date": "2025-01-25",
      "last_updated": "2025-07-08"
    },
    {
      "title": "[PDF] ASEAN GUIDELINE ON STABILITY STUDY OF DRUG PRODUCT",
      "url": "https://asean.org/wp-content/uploads/i-Final-ASEAN-Guideline-on-Stability-Study-Drug-Product-R2_uniformed-template.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    }
  ]
}